BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20596609)

  • 1. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.
    Gaida MM; Haag N; Günther F; Tschaharganeh DF; Schirmacher P; Friess H; Giese NA; Schmidt J; Wente MN
    Int J Mol Med; 2010 Aug; 26(2):281-8. PubMed ID: 20596609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
    Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
    Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
    Doberstein K; Pfeilschifter J; Gutwein P
    Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
    Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
    Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.
    Prox J; Willenbrock M; Weber S; Lehmann T; Schmidt-Arras D; Schwanbeck R; Saftig P; Schwake M
    Cell Mol Life Sci; 2012 Sep; 69(17):2919-32. PubMed ID: 22446748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
    Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
    Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
    Zhang W; Liu S; Liu K; Wang Y; Ji B; Zhang X; Liu Y
    J Int Med Res; 2014 Jun; 42(3):611-8. PubMed ID: 24670536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
    Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
    Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.
    Wojtalewicz N; Sadeqzadeh E; Weiß JV; Tehrani MM; Klein-Scory S; Hahn S; Schmiegel W; Warnken U; Schnölzer M; de Bock CE; Thorne RF; Schwarte-Waldhoff I
    PLoS One; 2014; 9(3):e90461. PubMed ID: 24625754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
    Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
    Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
    Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
    J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [miR-140-5p affects the migration and invasion of hypopharyngeal carcinoma cells by downregulating ADAM10 expression].
    Jing P; Sa N; Xu W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 51(3):189-96. PubMed ID: 27033573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.
    Xu Q; Liu X; Chen W; Zhang Z
    J Transl Med; 2010 Dec; 8():136. PubMed ID: 21171968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.
    Riedle S; Kiefel H; Gast D; Bondong S; Wolterink S; Gutwein P; Altevogt P
    Biochem J; 2009 May; 420(3):391-402. PubMed ID: 19260824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.
    Mueller AC; Piper M; Goodspeed A; Bhuvane S; Williams JS; Bhatia S; Phan AV; Van Court B; Zolman KL; Peña B; Oweida AJ; Zakem S; Meguid C; Knitz MW; Darragh L; Bickett TE; Gadwa J; Mestroni L; Taylor MRG; Jordan KR; Dempsey P; Lucia MS; McCarter MD; Del Chiaro M; Messersmith WA; Schulick RD; Goodman KA; Gough MJ; Greene CS; Costello JC; Neto AG; Lagares D; Hansen KC; Van Bokhoven A; Karam SD
    Cancer Res; 2021 Jun; 81(12):3255-3269. PubMed ID: 33526513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
    Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
    Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
    Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.